{"pmid":32147516,"title":"Arguments in favor of remdesivir for treating SARS-CoV-2 infections.","text":["Arguments in favor of remdesivir for treating SARS-CoV-2 infections.","Int J Antimicrob Agents","Ko, Wen-Chien","Rolain, Jean-Marc","Lee, Nan-Yao","Chen, Po-Lin","Huang, Ching-Tai","Lee, Ping-Ing","Hsueh, Po-Ren","32147516"],"journal":"Int J Antimicrob Agents","authors":["Ko, Wen-Chien","Rolain, Jean-Marc","Lee, Nan-Yao","Chen, Po-Lin","Huang, Ching-Tai","Lee, Ping-Ing","Hsueh, Po-Ren"],"date":"2020-03-10T11:00:00Z","year":2020,"_id":"32147516","week":"202011|Mar 09 - Mar 15","doi":"10.1016/j.ijantimicag.2020.105933","keywords":["(COVID-19)","2019 Corona Virus Disease","Betacoronavirus","Remdesivir","SARS-CoV-2","Wuhan pneumonia"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1661359647802523648,"score":6.7365713,"similar":[]}